Allogene Therapeutics: Executives
David Chang, M.D., Ph.D.President and Chief Executive OfficerFY2022
Geoffrey ParkerExecutive Vice President and Chief Financial OfficerNot disclosed—
Zachary J. Roberts, M.D., Ph.D.Chief Medical Officer and Executive Vice President of Research and DevelopmentNot disclosed—
3 executives

Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.